Additionally, IFIX has been reported to reduce breast cancer cell metastasis by upregulating the metastasis suppressor maspin, potentially by degrading the histone deacetylase 1 (HDAC1) [39]. The gene discussed is HDAC1; the disease is breast carcinoma.